Francesca Nolan | executive |
Douglas Ingram | executive |
Dallan Murray | executive |
Louise Rodino-Klapac | executive |
Ian Estepan | executive |
Anupam Rama | analyst |
Tazeen Ahmad | analyst |
Huidong Wang | analyst |
Colin Bristow | analyst |
Brian Skorney | analyst |
Salveen Richter | analyst |
Uy Ear | analyst |
Danielle Brill | analyst |
Tim Lugo | analyst |
Ritu Baral | analyst |
Gil Blum | analyst |
Brian Abrahams | analyst |
Mary Jenkins | executive |
Joseph Schwartz | analyst |
Good afternoon, and welcome to the Sarepta Therapeutics Third Quarter 2023 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded. At this time, I'll turn the call over to Francesca Nolan, Executive Director, Investor Relations and Corporate Communications. Please go ahead.
Thank you, Michelle, and thank you all for joining today's call.